glp-1 shortage fda Ends Compounding of Drugs as Shortages Improve, The U.S. Food and Drug Administration (FDA) has announced the end of the for GLP-1 weight loss drugs like Ozempic, leading to the Compounded GLP-1s: Why doctors worry
Description
Diabetes, Obesity & Metabolism, 26 (10), 44804489

Do results last after stopping treatment
Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy

Protein often drops